Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genetic profiles in diffuse large B-cell lymphoma

ABSTRACT: Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets

PROVIDER: PRJEB19228 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR1810770.fastq.gz	Fastqsanger.gz
	ERR1810770_1.fastq.gz	Fastqsanger.gz
	ERR1810770_2.fastq.gz	Fastqsanger.gz
	ERR1810780.fastq.gz	Fastqsanger.gz
	ERR1810780_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 450

Similar Datasets

Gene and microRNA expression data of diffuse large B cell lymphoma from human diagnostic frozen samples

Project description:This SuperSeries is composed of the following subset Series: GSE21846: Transcriptional profiling of 29 cases of diffuse large B cell lymphoma GSE21847: miRNA profiling of 29 cases of diffuse large B cell lymphoma GSE21848: miRNA profiling of 36 cases of diffuse large B cell lymphoma Refer to individual Series

2011-08-01 | E-GEOD-21849 | biostudies-arrayexpress

caArray_golub-00095: Diffuse large B-cell lymphoma outcome prediction

Project description:Diffuse large B-cell lymphoma (DLBCL), the most common lymphoid malignancy in adults, is curable in less than 50% of patients. Prognostic models based on pre-treatment characteristics, such as the International Prognostic Index (IPI), are currently used to predict outcome in DLBCL. However, clinical outcome models identify neither the molecular basis of clinical heterogeneity, nor specific therapeutic targets. We analyzed the expression of 6,817 genes in diagnostic tumor specimens from DLBCL patients who received cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)-based chemotherapy, and applied a supervised learning prediction method to identify cured versus fatal or refractory disease. The algorithm classified two categories of patients with very different five-year overall survival rates (70% versus 12%). The model also effectively delineated patients within specific IPI risk categories who were likely to be cured or to die of their disease. Genes implicated in DLBCL outcome included some that regulate responses to B-cell-receptor signaling, critical serine/threonine phosphorylation pathways and apoptosis. Our data indicate that supervised learning classification techniques can predict outcome in DLBCL and identify rational targets for intervention. golub-00095 Assay Type: Gene Expression Provider: Affymetrix Array Designs: Hu6800 Organism: Homo sapiens (ncbitax) Tissue Sites: Lymphoid tissue Material Types: synthetic_DNA, synthetic_RNA, organism_part Cell Types: B-Lymphocyte Disease States: Diffuse large B-cell Lymphoma, Follicular Lymphoma

2015-05-15 | E-GEOD-68895 | biostudies-arrayexpress

Diffuse large B-cell lymphoma (DLBCL) from primary sites and metastatic lymph nodes

Project description:Analysis of diffuse large B-cell lymphoma (DLBCL) from primary sites (named as S1, S2 and S3) and metastatic lymph nodes (named as L1, L2 and L3). Results provide insight into the targets involved in t DLBCL dissemination.

2017-06-30 | GSE81968 | GEO

Chip-chip from mouse diffuse large B cell lymphoma cell lines with IRF8

Project description:IRF8, a transcriptional factor, has the heightened expression in germinal center(GC) B cell and GC-origin B cell lymphoma. To identify IRF8 direct targets in GC B cells, ChIP-chip ananlysis was done in three different GC-origin diffuse large B cell lymphoma cell lines. IRF8-negative cell lines, MPC11, was also used as a negatvie control.

2011-10-15 | GSE30519 | GEO

Chip-chip from human diffuse large B cell lymphoma cell lines with IRF8

2011-10-15 | GSE30357 | GEO

Pathogenesis of Diffuse Large B-cell Lymphoma Proteogenotypes

Project description:Pathogenesis of Diffuse Large B-cell Lymphoma Proteogenotypes

| PRJNA1438157 | ENA

EGR1 addiction in diffuse large B cell lymphoma

Project description:EGR1 addiction in diffuse large B cell lymphoma

| PRJNA508194 | ENA

Canine diffuse large B-Cell lymphoma sequencing data

Project description:Canine diffuse large B-Cell lymphoma sequencing data

| PRJEB77298 | ENA